in

Leaked: Pfizer SAFETY DATA SHEET

Section 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Since When Did You Trust Big Pharma? Seriously!
Since When Did You Trust Big Pharma? Seriously!

page1image18640592

Revision date 19-Mar-2021

1.1. Product identifier Product Name

Product Code(s) Form Synonyms

Trade Name: Compound Number Item Code Chemical Family:

Version 2 Page 1 / 12

Pfizer-BioNTech COVID-19 Vaccine

PF00092
nanoform
Comirnaty; PF-07302048 containing PF-07305885 (BNT162b2); CorVAC Containing PF-07305885 (BNT162b2) ; CoVVAC Containing PF-07305885 (BNT162b2); COVID Vaccine Containing PF-07305885 (BNT162b2); COVID-19 Vaccine Containing PF-07305885 (BNT162b2)
Not applicable
PF-07302048
H000022941: H000023057;H000024547: H000024742
Lipid Nanoparticles containing PF-07305885 (BNT162b2) and Lipids

SAFETY DATA SHEET

page1image18749664

Section 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

page1image18756880 page1image18757152

1.2. Relevant identified uses of the substance or mixture and uses advised against Recommended Use Pharmaceutical product
1.3. Details of the supplier of the safety data sheet

page1image18772208 page1image18772480 page1image18772752 page1image18773024

Pfizer Inc
235 East 42nd Street
New York, New York 10017 1-800-879-3477

1.4. Emergency telephone number

Emergency Telephone

E-mail address

Pfizer Ireland Pharmaceuticals OSG Building
Ringaskiddy, Co. Cork.
Ireland

+353 21 4378701

Chemtrec 1-800-424-9300 International Chemtrec (24 hours):+1-703-527-3887 pfizer-MSDS@pfizer.com

page1image18800624 page1image18800896 page1image18801168

Section 2: HAZARDS IDENTIFICATION

2.1. Classification of the substance or mixture

page1image18808784 page1image18809056

Not classified as hazardous

2.2. Label elements Signal word

Hazard statements

2.3. Other hazards Other hazards

Note:

Not classified
Not classified in accordance with international standards for workplace safety.

An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).

This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless

page1image14559696 page1image14559968 page1image14560784 page1image14561056 page1image14561328

PF00092

SAFETY DATA SHEET
Product Name Pfizer-BioNTech COVID-19 Vaccine Page 2 / 12

Revision date 19-Mar-2021

Version 2

of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

Not applicable

page2image15969088

Section 3:

COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances Substances

3.2 Mixtures

page2image15948096 page2image15948304 page2image4191477776 page2image4191478048

Hazardous

page2image16411056 page2image13494064 page2image4274904512 page2image4274898816 page2image13380224 page2image4191525360 page2image13461424 page2image4193193312 page2image4193193776 page2image4193193984 page2image13338816 page2image13339024 page2image13339296 page2image13339568

Chemical name

Weight-%

REACH Registration Number

EC No

Classification according to Regulation (EC) No. 1272/2008 [CLP]

Specific concentration limit (SCL)

M-Factor

M-Factor (long-term)

page2image4193193584 page2image13479184 page2image4274454928 page2image4274455200 page2image4274455472 page2image4274455744 page2image4274456016 page2image4274445104 page2image4274445376 page2image4274445648 page2image4192094656 page2image4192094928 page2image4192095200 page2image4192095744 page2image4191705840 page2image4191706048 page2image4191706320 page2image4191706592 page2image4274895776 page2image4274895984 page2image4274896528 page2image16344304 page2image16344576 page2image16344848

Sucrose 57-50-1

< 10

200-334-9

No data

Not Listed

No data

No data

page2image15735696 page2image15735968 page2image16341136

available

available

available

page2image16458576 page2image16459168 page2image16121904 page2image16122176 page2image16122448 page2image16122720 page2image16122992 page2image16123536 page2image16123808 page2image16124080 page2image16139040 page2image16139312 page2image16139584 page2image16139856 page2image16140128 page2image16140400 page2image16140672 page2image16141216 page2image16141488 page2image16141760 page2image16142032

SODIUM CHLORIDE 7647-14-5

< 10

231-598-3

No data

Not Listed

No data

No data

page2image16193152 page2image13207088 page2image13207360

available

available

available

page2image16569680 page2image16569952 page2image15933440 page2image15970400 page2image15970608 page2image15971088 page2image15971360 page2image15971632 page2image15971904 page2image15972176 page2image16525008 page2image16525280 page2image16525552 page2image16525824 page2image16526096 page2image16526688 page2image16526896 page2image16527168 page2image15978544 page2image15978816 page2image15979088

Potassium phosphate 7778-77-0

<1

231-913-4

No data

Not Listed

No data

No data

page2image15929888 page2image15930160 page2image16468368

available

available

available

page2image16423904 page2image16424176 page2image16424768 page2image16425360 page2image16425632 page2image16425904 page2image16426176 page2image16426448 page2image16617232 page2image16617440 page2image16617712 page2image16617984 page2image16618256 page2image16619600 page2image16619984 page2image16535472 page2image16623120page2image16623856 page2image16515504 page2image16516032

POTASSIUM CHLORIDE 7447-40-7

<1

231-211-8

No data available

Not Listed

No data available

No data available

page2image4191697600 page2image4191697872 page2image16519216 page2image16519488 page2image16519760 page2image16361280

NonHazardous

Chemical name

page2image16297344

Weight-%

page2image16085888 page2image16083792

REACH Registration Number

page2image16495376

EC No

Classification according to Regulation (EC) No. 1272/2008 [CLP]

page2image16579824

Specific concentration limit (SCL)

M-Factor

M-Factor (long-term)

Water 7732-18-5

*

231-791-2

No data available

Not Listed

No data available

No data available

ALC-0315 2036272-55-4

<2

Not Listed

No data available

Not Listed

No data available

No data available

PF-07305885 –

<1

Not Listed

No data available

Not Listed

No data available

No data available

PF-07302048 –

<1

Not Listed

No data available

Not Listed

No data available

No data available

PEGA / ALC-0159 –

<1

Not Listed

No data available

Not Listed

No data available

No data available

Disodium phosphate dihydrate

10028-24-7

<1

Not Listed

No data available

Not Listed

No data available

No data available

Cholesterol 57-88-5

<1

200-353-2

No data available

Not Listed

No data available

No data available

1,2-Distearoyl-sn-glyc ero-3-phosphocholine 816-94-4

<1

212-440-2

No data available

Not Listed

No data available

No data available

Full text of H- and EUH-phrases: see section 16

page2image16367152 page2image16367424

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Page 3 / 12 Version 2

Revision date 19-Mar-2021

Acute Toxicity Estimate

page3image18305088 page3image4236072304

page3image4190462640 page3image20082832 page3image18613376 page3image4194004640 page3image4270712544

Chemical name

Oral LD50

Dermal LD50

Inhalation LC50 – 4 hour – dust/mist – mg/L

No data available

Inhalation LC50 – 4 hour – vapor – mg/L

No data available

Inhalation LC50 – 4 hour – gas – ppm

page3image11268128 page3image4193364080 page3image18440432 page3image18540816 page3image4193441552 page3image18026000 page3image4269958112 page3image11254496 page3image11510864 page3image18540368 page3image17858880 page3image4235995424 page3image4269951904 page3image4270980240 page3image4271235664 page3image11387984 page3image4190327712 page3image18052544 page3image4271054768 page3image4190694112

Water 7732-18-5

page3image4190832752 page3image4191028944 page3image11331760 page3image4235786128

89838.9

No data available

No data available

page3image17933152 page3image4271633104 page3image4235849168 page3image18119568 page3image18118176 page3image18483136 page3image4269850912 page3image4270734128 page3image4271615920 page3image4193538880 page3image4271610080 page3image4194269792 page3image4193798832 page3image11341840 page3image18627456 page3image4193763184page3image4190773504 page3image4193829120 page3image4270551408

Sucrose 57-50-1

29700

No data available

No data available

No data available

No data available

page3image4269992528 page3image11322624 page3image4193659872 page3image20081456 page3image20099984 page3image4193564848 page3image4193565056 page3image4193546208 page3image4193546416 page3image18611152 page3image18600896 page3image11257536 page3image11257744 page3image11508624 page3image18341888 page3image18595904 page3image18032368page3image4235776864

SODIUM CHLORIDE 7647-14-5

3000

10000

No data available

No data available

No data available

page3image18094704 page3image4190161040 page3image18549504 page3image4190161360 page3image4270936416 page3image20057712 page3image20098752 page3image20095440 page3image20092192 page3image4271519792 page3image4271520000 page3image4270967280 page3image4270967488

Potassium phosphate 7778-77-0

3200

No data available

No data available

No data available

No data available

page3image4193665360 page3image4271175984 page3image18062928 page3image4235313008 page3image4235313216 page3image4190738128 page3image4271618032 page3image4271186736 page3image4235640720 page3image4235640928 page3image4190307632 page3image4190307904 page3image4271223232

POTASSIUM CHLORIDE 7447-40-7

2600

No data available

No data available

No data available

No data available

page3image13942544 page3image14625920 page3image15287984 page3image13741520 page3image15394464 page3image15338272 page3image15239040 page3image14542880 page3image14920320 page3image15463296 page3image15463408page3image14956208 page3image14956320

Cholesterol 57-88-5

No data available

2000

No data available

No data available

No data available

Looks pretty harmless so far based on all the above data !!!

Additional information

– Not Assigned

* Proprietary
Non-hazardous ingredients provided for completeness. Ingredient(s) indicated as hazardous have been assessed under standards for workplace safety. In accordance with 29 CFR 1910.1200, the exact percentage composition of this mixture has been withheld as a trade secret.

page3image14807072

Section 4: FIRST AID MEASURES

4.1. Description of first aid measures

page3image15140864 page3image15141136

Inhalation Eye contact

Skin contact Ingestion

Remove to fresh air. Seek immediate medical attention/advice.

Rinse thoroughly with plenty of water for at least 15 minutes, lifting lower and upper eyelids. Consult a physician.

Remove contaminated clothing. Flush area with large amounts of water. Use soap. Seek medical attention.

Never give anything by mouth to an unconscious person. Wash out mouth with water. Do not induce vomiting unless directed by medical personnel. Seek medical attention immediately.

4.2. Most important symptoms and effects, both acute and delayed

Most important symptoms and No data available effects

4.3. Indication of any immediate medical attention and special treatment needed Note to physicians None.

5.1. Extinguishing media
Suitable Extinguishing Media Dry chemical, CO2, alcohol-resistant foam or water spray.

page3image15332400

Section 5: FIRE-FIGHTING MEASURES

page3image15419376 page3image15419648 page3image15419920

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

5.2. Special hazards arising from the substance or mixture

Page 4 / 12 Version 2

page4image4190831312 page4image4190831520 page4image4190831728

Specific hazards arising from the chemical

Hazardous combustion products 5.3. Advice for firefighters

Special protective equipment for fire-fighters

Fine particles (such as mists) may fuel fires/explosions. Formation of toxic gases is possible during heating or fire.

page4image4232684048 page4image17516000

Firefighters should wear self-contained breathing apparatus and full firefighting turnout gear. Use personal protection equipment.

page4image17415200

Section 6: ACCIDENTAL RELEASE MEASURES

6.1. Personal precautions, protective equipment and emergency procedures

page4image18655760 page4image4270192048

Personal precautions
For emergency responders
6.2. Environmental precautions Environmental precautions

Personnel involved in clean-up should wear appropriate personal protective equipment (see Section 8). Minimize exposure.
Use personal protection recommended in Section 8.

Place waste in an appropriately labeled, sealed container for disposal. Care should be taken to avoid environmental release.

page4image18279536 page4image18279808

6.3. Methods and material for containment and cleaning up

page4image20088496 page4image20088768

Methods for containment Methods for cleaning up

Prevention of secondary hazards 6.4. Reference to other sections Reference to other sections

7.1. Precautions for safe handling

Advice on safe handling

Prevent further leakage or spillage if safe to do so.
Contain the source of spill if it is safe to do so. Collect spill with absorbent material. Clean spill area thoroughly.
Clean contaminated objects and areas thoroughly observing environmental regulations.

See section 8 for more information. See section 13 for more information.

page4image20075424 page4image20075696 page4image20075968

Section 7: HANDLING AND STORAGE

page4image11335984 page4image11336256

Restrict access to work area. No open handling permitted. Minimize generating airborne mists and vapors. If solvent based liquid, ground and bond all bulk transfer equipment. Use appropriate engineering controls to maintain exposures below the B-OEB taking all applicable routes of exposure into consideration. A change area to facilitate ‘good laboratory/manufacturing’ decontamination practices is recommended. Avoid inhalation and contact with skin, eye, and clothing. When handling, use appropriate personal protective equipment (see Section 8). Wash hands and any exposed skin after removal of PPE. Releases to the environment should be avoided. Review and implement appropriate technical and procedural waste water and waste disposal measures to prevent occupational exposure or environmental releases. Potential points of process emissions of this material to the atmosphere should be controlled with dust collectors, HEPA filtration systems or other equivalent controls.

General hygiene considerations Handle in accordance with good industrial hygiene and safety practice.
7.2. Conditions for safe storage, including any incompatibilities
Storage Conditions Store at < -70 °C in properly labeled containers. Keep away from heat, sparks, and flames. 7.3. Specific end use(s)
Specific use(s) Vaccine.

page4image19988432 page4image19988704 page4image19988976 page4image19989248page4image19989520

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

8.1. Control parameters Exposure Limits

Refer to available public information for specific member state Occupational Exposure Limits.

Page 5 / 12 Version 2

page5image18894304page5image18894576

Section 8: EXPOSURE CONTROLS/PERSONAL PROTECTION

page5image18899024 page5image18899360

Sucrose

ACGIH TLV Bulgaria Estonia France Ireland

Latvia Spain OSHA PEL

United Kingdom

SODIUM CHLORIDE

Latvia

Russia

Potassium phosphate

Russia

POTASSIUM CHLORIDE

Bulgaria Latvia Russia

Pfizer OEB Statement:

SODIUM CHLORIDE

Pfizer Occupational Exposure

Band (OEB):

ALC-0315

Pfizer Occupational Exposure

Band (OEB):

POTASSIUM CHLORIDE

Pfizer Occupational Exposure

Band (OEB):

PF-07305885

Pfizer Occupational Exposure

Band (OEB):

PF-07302048

Pfizer Occupational Exposure

Band (OEB):

8.2. Exposure controls Engineering controls

10 mg/m3
10.0 mg/m3
10 mg/m3
10 mg/m3
10 mg/m3
STEL: 20 mg/m3 5 mg/m3

10 mg/m3
15 mg/m3
5 mg/m3
(vacated) TWA: 15 mg/m3 total dust (vacated) TWA: 5 mg/m3 respirable fraction TWA: 10 mg/m3

STEL: 20 mg/m3

5 mg/m3
MAC: 5 mg/m3

MAC: 10 mg/m3

5.0 mg/m3
5 mg/m3
MAC: 5 mg/m3

The Biotherapeutic Occupational Exposure Band (B-OEB) is an acceptable daily intake (ADI) range, based on available hazard data with appropriate safety factors applied. Engineering control measures should be utilized to bring exposures into the relevant B-OEB; supplementary administrative controls and personal protective equipment are to be used to achieve exposure control to the bottom of the band.

OEB 1 (control exposure to the range of 1000ug/m3 to 3000ug/m3)

OEB 3 – Contact Hazards Unknown (control exposure to the range of 10ug/m3 to < 100ug/m3)

OEB 1 (control exposure to the range of 1000ug/m3 to 3000ug/m3)
B-OEB Default (control exposure to the range of 10 μg/day to <100 μg/day) B-OEB 5 (control exposure to <10 μg/day)

Engineering controls should be used as the primary means to control exposures. Use process containment, local exhaust ventilation, biosafety cabinet, or other engineering controls to maintain airborne levels within the B-OEB range. It is recommended that all large scale operations should be fully enclosed. Air recirculation is not recommended.

page5image20184640 page5image20185040 page5image20185312

PF00092

SAFETY DATA SHEET
Product Name Pfizer-BioNTech COVID-19 Vaccine Page 6 / 12

Revision date 19-Mar-2021

Environmental exposure controls

Personal protective equipment

Eye/face protection

Hand protection

Skin and body protection

Respiratory protection

General hygiene considerations

Version 2

page6image20260448

No information available.

Contact your safety and health professional or safety equipment supplier for assistance in selecting the correct protective clothing/equipment based on an assessment of the workplace conditions, other chemicals used or present in the workplace and specific operational processes. Refer to applicable national standards and regulations in the selection and use of personal protective equipment (PPE).

Wear safety glasses as minimum protection (goggles recommended). (Eye protection must meet the standards in accordance with EN166, ANSI Z87.1 or international equivalent.).

Wear impervious disposable gloves (e.g. Nitrile, etc.) as minimum protection (double recommended). (Protective gloves must meet the standards in accordance with EN374, ASTM F1001 or international equivalent.).

(Protective clothing must meet the standards in accordance with EN13982, ANSI 103 or international equivalent.).

Under normal conditions of use, if the applicable Biotherapeutic Occupational Exposure Band (B-OEB) is exceeded, wear an appropriate respirator with a protection factor sufficient to control exposures to below the B-OEB (e.g. particulate respirator with a full mask, P3 filter). (Respirators must meet the standards in accordance with EN136, EN143, ASTM F2704-10 or international equivalent.).

Handle in accordance with good industrial hygiene and safety practice.

page6image20542944 page6image20543280

9.1. Information on basic physical and chemical properties Physical state
Color
Odor

Odor threshold Molecular formula Molecular weight

Property
pH
Melting point / freezing point Boiling point / boiling range Flash point
Evaporation rate Flammability (solid, gas) Flammability Limit in Air

Upper flammability limit:

Lower flammability limit:

Vapor pressure
Vapor density
Relative density
Water solubility Solubility(ies)
Partition coefficient Autoignition temperature

Liquid milky white

Mixture Mixture

Values

7.4

No data available

No data available No data available

protection is recommended (scale dependent). Wear impervious protective clothing when

page6image20599616

handling this compound.

No information available.

No information available

page6image20609984 page6image20610256

No data available No data available

No data available No data available No data available No data available No data available

page6image20625008

PF00092

Wear impervious disposable protective clothing when handling this compound. Full body

page6image20633408

Section 9: PHYSICAL AND CHEMICAL PROPERTIES

No information available

If this compound is so risky to the body,

page6image20644080

then why on earth would you inject it into the body ???

page6image20649792 page6image20650064

No data available No data available

page6image20653760

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

Decomposition temperature Kinematic viscosity Dynamic viscosity
Particle characteristics

Particle Size

Particle Size Distribution Explosive properties

9.2. Other information

No information available

9.2.1. Information with regard to physical hazard classes

Page 7 / 12 Version 2

page7image19540048 page7image19540320

No information available No information available

No information available

No information available

9.2.2. Other safety characteristics

No information available

10.1. Reactivity Reactivity
10.2. Chemical stability Stability
Explosion data

Sensitivity to Mechanical Impact Sensitivity to Static Discharge

No data available.

Stable under normal conditions.

page7image19576624

Section 10: STABILITY AND REACTIVITY

page7image19580432 page7image19580960 page7image19581376 page7image19581648

No data available.

No data available.

10.3. Possibility of hazardous reactions

page7image14639888 page7image22627776

Possibility of hazardous reactions

No information available.

page7image22730528 page7image22730800

10.4. Conditions to avoid
Conditions to avoid Fine particles (such as mists) may fuel fires/explosions. As a precautionary measure, keep

page7image22742208 page7image22742480

away from heat sources and electrostatic discharge. Incompatible materials As a precautionary measure, keep away from strong oxidizers.

10.5. Incompatible materials
10.6. Hazardous decomposition products

page7image22759792 page7image22760064

Hazardous decomposition products No data available.

11.1. Information on hazard classes as defined in Regulation (EC) No 1272/2008 General Information:
Known Clinical Effects:

Acute Toxicity: (Species, Route, End Point, Dose) Sucrose
Rat Oral LD 50 29,700 mg/kg

SODIUM CHLORIDE

Rat Sub-tenon injection (eye) LC50/1hr > 42 g/m3 Rat Oral LD 50 3 g/kg

Section 11:

TOXICOLOGICAL INFORMATION

page7image22604672 page7image22602352

Toxicological properties have not been thoroughly investigated. The following information is

page7image22172976

available for the individual ingredients.

page7image22578064 page7image22578336

Based on clinical trials in humans, possible adverse effects following intravenous exposure

page7image22557424

to this compound may include: injection site pain, muscle pain, headache, fever, chills,

page7image22610608

tiredness, joint pain, abnormal redness of skin (erythema), and sleep disturbances. Serious

page7image22618368

allergic reactions, including anaphylaxis, have been reported.

page7image22219008 page7image22219280 page7image22219552page7image22219824

PF00092

No data available No data available No data available

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

Mouse Oral LD 50 4 g/kg Rabbit Dermal LD 50 > 10 g/kg POTASSIUM CHLORIDE
Rat Oral LD50 2600 mg/kg Potassium phosphate

Rat Oral LD50 3200 mg/kg
Rabbit Dermal LC50 > 4640 mg/kg

Page 8 / 12 Version 2

page8image20355728 page8image20356000 page8image20356272

Chemical name

Oral LD50

Dermal LD50

Inhalation LC50

Water

>90mL/kg (Rat)

Sucrose

= 29700 mg/kg ( Rat )

SODIUM CHLORIDE

=3g/kg (Rat)

> 10000 mg/kg ( Rabbit )

>42g/m3 (Rat)1h

Potassium phosphate

=3200mg/kg (Rat)

POTASSIUM CHLORIDE

=2600mg/kg (Rat)

Cholesterol

>2000mg/kg (Rat)

page8image4192047120

Irritation / Sensitization: (Study Type, Species, Severity) SODIUM CHLORIDE
Skin irritation Rabbit Mild
Eye irritation Rabbit Mild

POTASSIUM CHLORIDE

Eye Irritation Rabbit Mild

page8image16210080 page8image4191565296 page8image13247248

Repeated Dose Toxicity: (Duration, Species, Route, Dose, End Point, Target Organ)
PF-07302048
4 Week(s) Rat Intramuscular * 10 μg LOAEL Skin, Blood forming organs, Blood, Skeletal muscle, Lymphoid tissue, Spleen Repeated Dose Toxicity Comments: PF-07302048: * Doses were administered once a week.

Reproduction & Development Toxicity: (Duration, Species, Route, Dose, End Point, Effect(s))
PF-07305885
Fertility & Embryonic Development – Females Rat Intramuscular 30 μg NOAEL No effects at maximum dose, Not teratogenic
Potassium phosphate
Reproductive & Fertility Rat No route specified 282 mg/kg/day NOAEL No evidence of impaired fertility or harm to the fetus Reproductive & Fertility Mouse No route specified 320 mg/kg/day NOAEL No evidence of impaired fertility or harm to the fetus

page8image21191264 page8image21191536page8image21191808 page8image21192080 page8image21192352

Genetic Toxicity: (Study Type, Cell Type/Organism, Result) Potassium phosphate

page8image21199104 page8image21199632

Bacterial Mutagenicity (Ames)

Carcinogenicity Cholesterol

IARC

Salmonella Negative See below

Group 3 (Not Classifiable)

page8image21210608

Data for the Drug Product
Reproduction & Development Toxicity: (Study Type, Species, Route, Dose, End Point, Effect(s))

page8image21220752

Fertility & Embryonic Rat Intramuscular N/A Development – Females

11.2. Informationonotherhazards

Not specified

No effects at maximum dose

page8image21233232 page8image21233504 page8image21233776

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

11.2.1. Endocrine disrupting properties

Page 9 / 12 Version 2

page9image12471536

Endocrine disrupting properties

11.2.2. Otherinformation Other adverse effects

Environmental Overview:

12.1. Toxicity

No information available.

No information available.

page9image17696960

Section 12: ECOLOGICAL INFORMATION

Environmental properties have not been investigated. Releases to the environment should be avoided.

page9image22037280 page9image22037552

Aquatic Toxicity: (Species, Method, End Point, Duration, Result) POTASSIUM CHLORIDE

Gambusia affinis (Mosquitofish) LC50 96 hours 920 mg/L
Lepomis macrochirus (Bluegill Sunfish) LC50 96 hours 2010 mg/L Daphnia Magna (Water Flea) EC50 48 hours 825 mg/L Scenedesmus subspicatus (Green Alga) EC50 72 hours 2500 mg/L

page9image15950848 page9image16003984

12.2. Persistence and degradability Persistence and degradability

12.3. Bioaccumulative potential Bioaccumulation

12.4. Mobility in soil Mobility in soil

No information available.

No information available.

No information available.

page9image22045552 page9image22045824 page9image22046560 page9image22040992 page9image22041408 page9image22041616 page9image22041888

12.5. Results of PBT and vPvB assessment PBT and vPvB assessment .

page9image15645824 page9image15646096

Chemical name

page9image15651808

PBT and vPvB assessment

SODIUM CHLORIDE

The substance is not PBT / vPvB PBT assessment does not apply

Potassium phosphate

The substance is not PBT / vPvB PBT assessment does not apply

POTASSIUM CHLORIDE

The substance is not PBT / vPvB PBT assessment does not apply

Cholesterol

The substance is not PBT / vPvB

12.6. Endocrinedisruptingproperties
Endocrine disrupting properties No information available.

12.7. Other adverse effects

No information available.

page9image15689248 page9image15689520 page9image15691136

PF00092

SAFETY DATA SHEET
Product Name Pfizer-BioNTech COVID-19 Vaccine Page 10 / 12

Revision date 19-Mar-2021

13.1. Waste treatment methods

Version 2

page10image19057968page10image19058240

Section 13: DISPOSAL CONSIDERATIONS

page10image17584112

Dispose of waste in accordance with all applicable laws and regulations. Member State specific and Community specific provisions must be considered. Considering the relevant known environmental and human health hazards of the material, review and implement appropriate technical and procedural wastewater and waste disposal measures to prevent occupational exposure and environmental release. It is recommended that waste minimization be practiced. The best available technology should be utilized to prevent environmental releases. This may include destructive techniques for waste and wastewater.

The following refers to all modes of transportation unless specified below.

Not regulated for transport under USDOT, EUADR, IATA, or IMDG regulations.

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture

page10image19127680

Section 14: TRANSPORT INFORMATION

page10image19131024

Section 15: REGULATORY INFORMATION

page10image19134368 page10image19134640

Water

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA
EINECS

AICS

Sucrose

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA
EINECS

AICS

SODIUM CHLORIDE

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA
EINECS

AICS

ALC-0315

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS

Potassium phosphate

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA
EINECS

AICS

POTASSIUM CHLORIDE

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA

Not Listed Not Listed Present 231-791-2 Present

Not Listed Not Listed Present 200-334-9 Present

Not Listed Not Listed Present 231-598-3 Present

Not Listed Not Listed Not Listed

Not Listed Not Listed Present 231-913-4 Present

Not Listed Not Listed Present

page10image19206720

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Page 11 / 12 Version 2

Revision date 19-Mar-2021

EINECS
AICS
Standard for Uniform Scheduling of Medicines and Poisons (SUSMP)

PF-07305885

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS

PF-07302048

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS

PEGA / ALC-0159

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS

Disodium phosphate dihydrate

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS
AICS

Standard for Uniform Scheduling of Medicines and

Poisons (SUSMP)

Cholesterol

CERCLA/SARA Section 313 de minimus % California Proposition 65
TSCA
EINECS

AICS
Standard for Uniform Scheduling of Medicines and Poisons (SUSMP)

1,2-Distearoyl-sn-glycero-3-phosphocholine

CERCLA/SARA Section 313 de minimus % California Proposition 65
EINECS

France
Occupational Illnesses (R-463-3, France)

European Union

231-211-8 Present Schedule 4

Not Listed Not Listed Not Listed

Not Listed Not Listed Not Listed

Not Listed Not Listed Not Listed

Not Listed Not Listed Not Listed Present Schedule 5

Not Listed Not Listed Present 200-353-2 Present Schedule 4

Not Listed Not Listed 212-440-2

page11image22709824

Chemical name

page11image20230272

French RG number

Title

SODIUM CHLORIDE 7647-14-5

RG 78

POTASSIUM CHLORIDE 7447-40-7

RG 67

Take note of Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

Authorizations and/or restrictions on use:

This product does not contain substances subject to authorization (Regulation (EC) No. 1907/2006 (REACH), Annex XIV) This product does not contain substances subject to restriction (Regulation (EC) No. 1907/2006 (REACH), Annex XVII)

Persistent Organic Pollutants

Not applicable

Ozone-depleting substances (ODS) regulation (EC) 1005/2009

Not applicable

page11image12261696

PF00092

SAFETY DATA SHEET Product Name Pfizer-BioNTech COVID-19 Vaccine

Revision date 19-Mar-2021

Plant protection products directive (91/414/EEC)

Page 12 / 12 Version 2

page12image22181616

Chemical name

Plant protection products directive (91/414/EEC)

Sucrose – 57-50-1

Plant protection agent

SODIUM CHLORIDE – 7647-14-5

Plant protection agent

Legend:
TSCA – United States Toxic Substances Control Act Section 8(b) Inventory
EINECS/ELINCS -EuropeanInventoryofExistingChemicalSubstances/EuropeanListofNotifiedChemicalSubstances AICS – Australian Inventory of Chemical Substances

15.2. Chemical safety assessment

Chemical Safety Report No information available

Key or legend to abbreviations and acronyms used in the safety data sheet

page12image22229456 page12image22231008

Section 16: OTHER INFORMATION

page12image22234112

Data Sources: Reason for revision

Revision date Prepared By

Pfizer proprietary drug development information. Publicly available toxicity information.

Updated Section 1 – Identification of the Substance/Preparation and the Company/Undertaking. Updated Section 3 – Composition / Information on Ingredients. Updated Section 11 – Toxicology Information. Updated Section 15 – Regulatory Information.

19-Mar-2021
Pfizer Global Environment, Health, and Safety

Pfizer Inc believes that the information contained in this Safety Data Sheet is accurate, and while it is provided in good

page12image22281728

faith, it is without warranty of any kind, expressed or implied. If data for a hazard are not included in this document there

page12image22292768

is no known information at this time.

page12image22296832 page12image22297104

Information is accurate ??? What information ???

page12image22301808

When the bulk of the information and data is listed as not available, and is not even provided; then no wonder there is no

page12image22312736

warranty for this vaccine.

That is like selling a dodgy second hand car; saying to the buyer that “information regarding potential faults and

problems is not available”; then reassuring the buyer that there is nothing to worry about, because the seller believes it

is an accurate statement !!!

The seller would go on to say, “we believe all the information we have provided about this car is accurate; however while

it is provided in good faith, it is without warranty of any kind, expressed or implied”.

page12image22358592

Who is ready to be a Guinea Pig ???

page12image22362624

After all, it is only your health and life at stake.

page12image22367904

For the thousands already killed by the COVID vaccine, and for the hundreds of thousands already seriously injured from

page12image22378240

the COVID jab; we can safely presume that none of them were shown this so-called Safety Data Sheet.

Written by Colin

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0